Timothy Kottke

7.1k total citations
83 papers, 5.6k citations indexed

About

Timothy Kottke is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Timothy Kottke has authored 83 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 44 papers in Molecular Biology and 43 papers in Genetics. Recurrent topics in Timothy Kottke's work include Virus-based gene therapy research (43 papers), CAR-T cell therapy research (34 papers) and Immunotherapy and Immune Responses (19 papers). Timothy Kottke is often cited by papers focused on Virus-based gene therapy research (43 papers), CAR-T cell therapy research (34 papers) and Immunotherapy and Immune Responses (19 papers). Timothy Kottke collaborates with scholars based in United States, United Kingdom and Spain. Timothy Kottke's co-authors include Richard G. Vile, Scott H. Kaufmann, Jill Thompson, Alan Melcher, Rosa María Díaz, Kevin J. Harrington, William C. Earnshaw, L. Miguel Martins, Phonphimon Wongthida and Peter J. Selby and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Timothy Kottke

82 papers receiving 5.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Timothy Kottke 3.0k 2.8k 2.4k 1.3k 543 83 5.6k
Roberto Weinmann 4.4k 1.5× 1.2k 0.4× 1.8k 0.8× 625 0.5× 315 0.6× 77 6.2k
Sunil Chada 2.4k 0.8× 2.8k 1.0× 2.5k 1.1× 1.9k 1.4× 220 0.4× 121 5.6k
Peter Sabbatini 2.0k 0.7× 1.4k 0.5× 936 0.4× 575 0.4× 189 0.3× 29 3.1k
Jose G. Teodoro 2.0k 0.7× 855 0.3× 1.0k 0.4× 481 0.4× 263 0.5× 47 3.4k
Hans Sjöström 1.5k 0.5× 1.2k 0.5× 1.8k 0.8× 452 0.3× 635 1.2× 122 5.4k
David Escors 1.6k 0.5× 2.4k 0.9× 677 0.3× 2.7k 2.1× 840 1.5× 128 5.5k
Albert B. DeLeo 3.3k 1.1× 3.2k 1.2× 1.0k 0.4× 4.5k 3.4× 109 0.2× 119 7.7k
Lawrence A. Chasin 6.0k 2.0× 632 0.2× 1.7k 0.7× 560 0.4× 254 0.5× 91 7.3k
Pradip Roy‐Burman 3.4k 1.2× 1.3k 0.5× 1.2k 0.5× 1.1k 0.9× 135 0.2× 125 6.0k
Richard Marcellus 2.4k 0.8× 724 0.3× 909 0.4× 483 0.4× 268 0.5× 38 3.3k

Countries citing papers authored by Timothy Kottke

Since Specialization
Citations

This map shows the geographic impact of Timothy Kottke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Kottke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Kottke more than expected).

Fields of papers citing papers by Timothy Kottke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Kottke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Kottke. The network helps show where Timothy Kottke may publish in the future.

Co-authorship network of co-authors of Timothy Kottke

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Kottke. A scholar is included among the top collaborators of Timothy Kottke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Kottke. Timothy Kottke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Driscoll, Christopher B., Matthew Schuelke, Timothy Kottke, et al.. (2020). APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy. Nature Communications. 11(1). 790–790. 49 indexed citations
2.
Evgin, Laura, Amanda L. Huff, Timothy Kottke, et al.. (2019). Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment. Cancer Immunology Research. 7(5). 828–840. 13 indexed citations
3.
Steele, Lynette P., Aat A. Mulder, Diana J.M. van den Wollenberg, et al.. (2018). Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy. Cancer Immunology Research. 6(10). 1161–1173. 53 indexed citations
4.
Cockle, Julia, Karishma Rajani, Shane Zaidi, et al.. (2015). Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling. Neuro-Oncology. 18(4). 518–527. 57 indexed citations
5.
Alonso-Camino, Vanesa, Karishma Rajani, Timothy Kottke, et al.. (2014). The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site. Molecular Therapy. 22(11). 1936–1948. 14 indexed citations
6.
Wongthida, Phonphimon, Rosa María Díaz, Karen M. Kaluza, et al.. (2012). Systemic Combination Virotherapy for Melanoma with Tumor Antigen-Expressing Vesicular Stomatitis Virus and Adoptive T-cell Transfer. Cancer Research. 72(18). 4753–4764. 44 indexed citations
7.
Kaluza, Karen M., et al.. (2012). Adoptive Transfer of Cytotoxic T Lymphocytes Targeting Two Different Antigens Limits Antigen Loss and Tumor Escape. Human Gene Therapy. 23(10). 1054–1064. 34 indexed citations
8.
Kottke, Timothy, Fiona Errington‐Mais, José S. Pulido, et al.. (2011). Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nature Medicine. 17(7). 854–859. 73 indexed citations
9.
Kottke, Timothy, John Chester, Elizabeth J. Ilett, et al.. (2011). Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy. Molecular Therapy. 19(10). 1802–1812. 22 indexed citations
10.
Kottke, Timothy, Geoff Hall, José S. Pulido, et al.. (2010). Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice. Journal of Clinical Investigation. 120(5). 1551–1560. 68 indexed citations
11.
Willmon, Candice, Kevin J. Harrington, Timothy Kottke, et al.. (2009). Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy. Molecular Therapy. 17(10). 1667–1676. 135 indexed citations
12.
Kaufmann, Scott H., Sun Hee Lee, X. Wei Meng, et al.. (2008). Apoptosis-associated caspase activation assays. Methods. 44(3). 262–272. 67 indexed citations
13.
Sánchez‐Pérez, Leonor, Michael J. Gough, Jian Qiao, et al.. (2007). Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells. Gene Therapy. 14(13). 998–1009. 14 indexed citations
14.
Sánchez-Pérez, Luis, Timothy Kottke, Gregory A. Daniels, et al.. (2006). Killing of Normal Melanocytes, Combined with Heat Shock Protein 70 and CD40L Expression, Cures Large Established Melanomas. The Journal of Immunology. 177(6). 4168–4177. 36 indexed citations
15.
Kottke, Timothy, Jian Qiao, Rosa María Díaz, et al.. (2006). The perforin-dependent immunological synapse allows T-cell activation-dependent tumor targeting by MLV vector particles. Gene Therapy. 13(15). 1166–1177. 12 indexed citations
16.
Meng, Xue, Joya Chandra, David A. Loegering, et al.. (2003). Central Role of Fas-associated Death Domain Protein in Apoptosis Induction by the Mitogen-activated Protein Kinase Kinase Inhibitor CI-1040 (PD184352) in Acute Lymphocytic Leukemia Cells in Vitro. Journal of Biological Chemistry. 278(47). 47326–47339. 43 indexed citations
17.
Blajeski, April L., Vy Phan, Timothy Kottke, & Scott H. Kaufmann. (2002). G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells. Journal of Clinical Investigation. 110(1). 91–99. 15 indexed citations
18.
Kottke, Timothy, April L. Blajeski, X. Wei Meng, et al.. (2002). Lack of Correlation between Caspase Activation and Caspase Activity Assays in Paclitaxel-treated MCF-7 Breast Cancer Cells. Journal of Biological Chemistry. 277(1). 804–815. 64 indexed citations
19.
Samejima, Kumiko, Phyllis A. Svingen, Guriqbal S. Basi, et al.. (1999). Caspase-mediated Cleavage of DNA Topoisomerase I at Unconventional Sites during Apoptosis. Journal of Biological Chemistry. 274(7). 4335–4340. 91 indexed citations
20.
Kaufmann, Scott H., Steven D. Gore, Louis Letendre, et al.. (1996). Factors Affecting Topotecan Sensitivity in Human Leukemia Samplesa. Annals of the New York Academy of Sciences. 803(1). 128–142. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Weinmann Breakdown of academic impact, for papers by Sunil Chada Breakdown of academic impact, for papers by Peter Sabbatini Breakdown of academic impact, for papers by Jose G. Teodoro Breakdown of academic impact, for papers by Hans Sjöström Breakdown of academic impact, for papers by David Escors Breakdown of academic impact, for papers by Albert B. DeLeo Breakdown of academic impact, for papers by Lawrence A. Chasin Breakdown of academic impact, for papers by Pradip Roy‐Burman Breakdown of academic impact, for papers by Richard Marcellus
Rankless by CCL
2026